– Commitment to CO2 accounting according to the globally recognized Greenhouse Gas Protocol
– ecovadis Platinum status achieved: Vetter is among the one percent of the most sustainable companies
– Sustainability goals are backed by concrete measures

Vetter, a globally leading Contract Development and M…

– Successful Re-Inspection of the New Location for Clinical Development in Austria
– Inspectors Were Impressed by Systems and Processes
– Rankweil Offers Services for the Manufacturing and Testing of Clinical Trial Preparations

Vetter, a globally leading Contract Development and Manufacturing Organizat…

– Focus on sustainable growth and long-term planning
– Individual investment of over €230 million in a new production building at the Ravensburg headquarters
– Further investments to increase efficiency and quality of development and manufacturing processes

Vetter, a globally leading Contract Developme…

We have been awarded the Frost & Sullivan’s 2023 Global Customer Value Leadership Award in the aseptic fill-and-finish market for the high performance for our customers. The award, presented annually by the international growth strategy consulting firm, focuses on both business and customer impa…

– Report now also includes Scope 3 emissions
– Social responsibility for employees is an important part of sustainability activities
– Total emissions to be reduced by ten percent by 2029

Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), continues its sustainability…

We have been recognized as Best Managed Company for the fourth time in a row – and now carrying gold status. The internationally renowned award is presented annually by Deloitte Private, Frankfurter Allgemeine Newspaper and the Federation of German Industries (BDI) to medium-sized and family-run com…

Vetter continues to drive the expansion of capacities and services for the provision of clinical trial materials: With the implementation of additional equipment for aseptic production and the expansion of storage capacities at the clinical site in Rankweil, Austria, we are responding to increasing…

Vetter earned the esteemed 2023 CDMO Leadership Awards in all six core categories – quality, expertise, reliability, capabilities, compatibility and service. In addition, we were awarded Champion Status for quality, expertise and compatibility – both recognitions for the second year in a row. In its…

Vetter has recently become a participant of the UN Global Compact Network (UN GC). We are one of the pioneers in the industry regarding responsible, sustainable, and transparent business practices. To date, only 308 biopharmaceutical companies worldwide have signed the UN Global Compact. By joining…

With the increasing drug development for novel therapeutics, a growing number of pharmaceutical and biotech companies are seeking clinical manufacturing partners to help meet the demand for complex fill and finish solutions. And, while the stages of early drug development are challenging, we are com…